CompuGroup Medical SE KGaA
Market Cap
€3.8b
Last Updated
2021/04/15 18:11 UTC
Data Sources
Company Financials +
Executive Summary
CompuGroup Medical SE & Co. KGaA develops and sells software and information technology solutions for the healthcare sector worldwide. More Details
Rewards
Risk Analysis
Snowflake Analysis
Adequate balance sheet average dividend payer.
Similar Companies
Share Price & News
How has CompuGroup Medical SE KGaA's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: COP is not significantly more volatile than the rest of German stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: COP's weekly volatility (4%) has been stable over the past year.
Market Performance
7 Day Return
2.6%
COP
2.9%
DE Healthcare Services
0.3%
DE Market
1 Year Return
7.9%
COP
15.6%
DE Healthcare Services
47.3%
DE Market
Return vs Industry: COP underperformed the German Healthcare Services industry which returned 15.6% over the past year.
Return vs Market: COP underperformed the German Market which returned 47.3% over the past year.
Shareholder returns
| COP | Industry | Market | |
|---|---|---|---|
| 7 Day | 2.6% | 2.9% | 0.3% |
| 30 Day | 4.2% | 3.7% | 5.0% |
| 90 Day | -8.2% | -7.7% | 8.7% |
| 1 Year | 8.7%7.9% | 16.4%15.6% | 52.1%47.3% |
| 3 Year | 76.8%72.7% | 74.1%69.8% | 23.2%12.6% |
| 5 Year | 113.6%105.1% | 125.1%115.4% | 49.8%28.5% |
Long-Term Price Volatility Vs. Market
How volatile is CompuGroup Medical SE KGaA's share price compared to the market and industry in the last 5 years?
Simply Wall St News
5 days ago | Simply Wall St
CompuGroup Medical SE KGaA (ETR:COP) Might Be Having Difficulty Using Its Capital Effectively2 weeks ago | Simply Wall St
I Built A List Of Growing Companies And CompuGroup Medical SE KGaA (ETR:COP) Made The Cut4 weeks ago | Simply Wall St
Is Compugroup Medical SE KGaA (ETR:COP) Using Too Much Debt?Valuation
Is CompuGroup Medical SE KGaA undervalued compared to its fair value and its price relative to the market?
51.95x
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: COP (€74.25) is trading above our estimate of fair value (€59.13)
Significantly Below Fair Value: COP is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: COP is poor value based on its PE Ratio (52x) compared to the DE Healthcare Services industry average (51.4x).
PE vs Market: COP is poor value based on its PE Ratio (52x) compared to the German market (28x).
Price to Earnings Growth Ratio
PEG Ratio: COP is poor value based on its PEG Ratio (3.8x)
Price to Book Ratio
PB vs Industry: COP is overvalued based on its PB Ratio (6.2x) compared to the DE Healthcare Services industry average (4.3x).
Future Growth
How is CompuGroup Medical SE KGaA forecast to perform in the next 1 to 3 years based on estimates from 8 analysts?
13.7%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: COP's forecast earnings growth (13.7% per year) is above the savings rate (0.07%).
Earnings vs Market: COP's earnings (13.7% per year) are forecast to grow slower than the German market (21% per year).
High Growth Earnings: COP's earnings are forecast to grow, but not significantly.
Revenue vs Market: COP's revenue (6.4% per year) is forecast to grow faster than the German market (5.4% per year).
High Growth Revenue: COP's revenue (6.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: COP's Return on Equity is forecast to be low in 3 years time (15.7%).
Past Performance
How has CompuGroup Medical SE KGaA performed over the past 5 years?
17.3%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: COP has high quality earnings.
Growing Profit Margin: COP's current net profit margins (8.4%) are lower than last year (8.5%).
Past Earnings Growth Analysis
Earnings Trend: COP's earnings have grown by 17.3% per year over the past 5 years.
Accelerating Growth: COP's earnings growth over the past year (11.3%) is below its 5-year average (17.3% per year).
Earnings vs Industry: COP earnings growth over the past year (11.3%) underperformed the Healthcare Services industry 11.3%.
Return on Equity
High ROE: COP's Return on Equity (11.5%) is considered low.
Financial Health
How is CompuGroup Medical SE KGaA's financial position?
Financial Position Analysis
Short Term Liabilities: COP's short term assets (€308.1M) exceed its short term liabilities (€290.5M).
Long Term Liabilities: COP's short term assets (€308.1M) do not cover its long term liabilities (€636.3M).
Debt to Equity History and Analysis
Debt Level: COP's debt to equity ratio (79.8%) is considered high.
Reducing Debt: COP's debt to equity ratio has reduced from 191.9% to 79.8% over the past 5 years.
Debt Coverage: COP's debt is well covered by operating cash flow (29.4%).
Interest Coverage: COP's interest payments on its debt are well covered by EBIT (30.8x coverage).
Balance Sheet
Dividend
What is CompuGroup Medical SE KGaA current dividend yield, its reliability and sustainability?
0.67%
Current Dividend Yield
Upcoming Dividend Payment
Dividend Yield vs Market
Notable Dividend: COP's dividend (0.67%) isn’t notable compared to the bottom 25% of dividend payers in the German market (1.06%).
High Dividend: COP's dividend (0.67%) is low compared to the top 25% of dividend payers in the German market (3.18%).
Stability and Growth of Payments
Stable Dividend: COP's dividends per share have been stable in the past 10 years.
Growing Dividend: COP's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (35%), COP's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: COP's dividends in 3 years are forecast to be well covered by earnings (25.9% payout ratio).
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
1.7yrs
Average management tenure
CEO
Dirk Wossner (51 yo)
0.25
Tenure
Dr. Dirk Wossner has been Chief Executive Officer and Chairman of Management Board at CompuGroup Medical SE & Co. KGaA since January 1, 2021. Dr. Wossner was a Member of the Board of Management at Deutsche...
Leadership Team
Experienced Management: COP's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.
Board Members
Experienced Board: COP's board of directors are not considered experienced ( 0.8 years average tenure), which suggests a new board.
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 10.2%.
Top Shareholders
Company Information
CompuGroup Medical SE & Co. KGaA's company bio, employee growth, exchange listings and data sources
Key Information
- Name: CompuGroup Medical SE & Co. KGaA
- Ticker: COP
- Exchange: XTRA
- Founded: 1987
- Industry: Health Care Technology
- Sector: Healthcare
- Market Cap: €3.802b
- Shares outstanding: 53.33m
- Website: https://www.cgm.com
Number of Employees
Location
- CompuGroup Medical SE & Co. KGaA
- Maria Trost 21
- Koblenz
- Rhineland-Palatinate
- 56070
- Germany
Listings
Biography
CompuGroup Medical SE & Co. KGaA develops and sells software and information technology solutions for the healthcare sector worldwide. It operates in four segments: Ambulatory Information Systems (AIS), Ph...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/04/15 18:11 |
| End of Day Share Price | 2021/04/15 00:00 |
| Earnings | 2020/12/31 |
| Annual Earnings | 2020/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.